Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Double-Blind Placebo and Active Comparator Controlled Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of MBX-8025 in Moderately Obese Hyperlipidemic Patients With/Out Concomitant Atorvastatin"

NCT00701883 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00701883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00701883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Double-Blind Placebo and Active Comparator Controlled Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of MBX-8025 in Moderately Obese Hyperlipidemic Patients With/Out Concomitant Atorvastatin"
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
August 31, 2008
Enrollment
183 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia